Abstract

e15514 Background: Cisplatin based chemotherapy is the tretment of choice in metastatic UC. Worldwide about 50% of patients do not receive this treatment. Available data on this issue are mising fo...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinicopathological characterization, FGFR alteration prevalence, and outcomes of locally advanced or metastatic urothelial cancer in Latin America (LACOG 1518).
...
Journal of Clinical Oncology | VOL. 40
, et. al. ...
01 Jun 2022
Beyond Cisplatin – I
Edward M Messing
Bladder Cancer | VOL. 2
Edward M MessingEdward M Messing
27 Jul 2016
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
J Bellmunt ... A Horwich
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 25
J Bellmunt, et. al.J Bellmunt ... A Horwich
01 Sep 2014
Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Vineet Talwar ... Venkata Pradeep Babu Koyyala
International Journal of Molecular and Immuno Oncology | VOL. 4
Vineet Talwar, et. al.Vineet Talwar ... Venkata Pradeep Babu Koyyala
14 Sep 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Michael D Jain ... Saurabh Dahiya
Journal of Clinical Oncology | VOL. -
Michael D Jain, et. al.Michael D Jain ... Saurabh Dahiya
02 Aug 2024
Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms
Melissa A Richard ... Ravi Bhatia
Journal of Clinical Oncology | VOL. -
Melissa A Richard, et. al.Melissa A Richard ... Ravi Bhatia
02 Aug 2024
Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality
Vinayak Venkataraman ... Suzanne George
Journal of Clinical Oncology | VOL. -
Vinayak Venkataraman, et. al.Vinayak Venkataraman ... Suzanne George
02 Aug 2024
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
Lori J Wirth ... Philippe A Cassier
Journal of Clinical Oncology | VOL. -
Lori J Wirth, et. al.Lori J Wirth ... Philippe A Cassier
02 Aug 2024
View more papers